Journal
JOURNAL OF ADVANCED PHARMACEUTICAL TECHNOLOGY & RESEARCH
Volume 11, Issue 4, Pages 194-201Publisher
WOLTERS KLUWER MEDKNOW PUBLICATIONS
DOI: 10.4103/japtr.JAPTR_178_19
Keywords
Glycogen synthase kinase 3 beta; in silico; molecular docking; molecular dynamics
Categories
Ask authors/readers for more resources
Glycogen synthase kinase 3 beta (GSK3 13) plays a key role in pathologic hyper phosphorylation of tau and plays an important role in the pathogenesis of Alzheimer's disease. In the present study, we have screened a set of potential hits in in silico platform to gain insight regarding binding profile with the target (GSK3 13) from molecular docking, ADME/T, and molecular dynamics (MD) simulations. The three screened compounds 6-BIBEO, 6-BIO, and SB216763 topped the docking score chart when subjected to hard scoring function extraprecision of GLIDE. The active site dynamics study through MD simulations provides insights on residues Asp133, Val135, and Ile62 which are in a state of minimum deviation from their mean special position while they interact with the respective ligands. The same molecules also displayed favorable pharmacokinetic profile, negative Ames test and falls correctly within drug-likeliness rules. These agents can be taken forward further for the development of anti-Alzheimer's drug therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available